TLX Competitors & Alternatives
Compare Telix Pharmaceuticals Limited with similar stocks in the same industry
Biotechnology
TLX
Main Stock$10.72
Tradestie Score
36
Market Cap
$3.40B
P/E Ratio
109.7
Revenue Growth
0.2%
Analyst Upside
+82.6%
Top Competitors
228 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
PTGX
Protagonist Therapeutics, Inc
|
$139.19
|
$3.98B | 136.8 | 67 | Compare |
|
CRNX
Crinetics Pharmaceuticals, Inc.
|
$84.95
|
$3.92B | - | 46 | Compare |
|
KYMR
Kymera Therapeutics, Inc. Common Stock
|
$110.12
|
$3.91B | - | 66 | Compare |
|
ZLAB
Zai Lab Limited American Depositary Shares
|
$25.50
|
$3.83B | - | 49 | Compare |
|
AAPG
Ascentage Pharma Group International American Depository Shares
|
$15.90
|
$3.68B | - | 60 | Compare |
|
MIRM
Mirum Pharmaceuticals, Inc. Common Stock
|
$83.92
|
$3.67B | - | 51 | Compare |
|
ADMA
ADMA Biologics, Inc.
|
$9.99
|
$3.59B | 14.3 | 29 | Compare |
|
ACAD
Acadia Pharmaceuticals Inc.
|
$19.89
|
$3.58B | 9.0 | 58 | Compare |
|
LGND
Ligand Pharmaceuticals Inc.
|
$302.74
|
$3.49B | 32.1 | 44 | Compare |
|
QURE
uniQure N.V.
|
$23.37
|
$3.39B | - | 46 | Compare |
More TLX Analysis
Data updated: Oct 02, 2026 | Industry: Biotechnology (SIC 2834)
228 stocks in this industry